| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | その他(不明) |
| 表題 | Patient-Reported Outcomes in Thoracic Surgery: An International Survey of European Society of Thoracic Surgeons (ESTS) and Japanese Association for Chest Surgery (JACS) Members. |
| 掲載誌名 | 正式名：European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 略 称：Eur J Cardiothorac Surg ISSNコード：1873734X/10107940 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 68(1),pp.ezag001 |
| 著者・共著者 | Cecilia Pompili, Aki K Kobayashi, Sara Lo Torto, Nuria M Novoa, Alessandro Bertani, Marcin Ostrowski, Shinnosuke Takamiya, Hiroyuki Suzuki, Hidehito Horinouchi, Masahiro Tsuboi, Shun-Ichi Watanabe, Yuichiro Kikawa, Ichiro Yoshino, Hideo Ichimura |
| 発行年月 | 2026/01 |
| 概要 | OBJECTIVES:This study aimed to evaluate the progress in the collection and interpretation of patient-reported outcomes (PRO) and Health-Related Quality of life (HRQoL) in thoracic surgery.METHODS:We invited all members of the European Society of Thoracic Surgeons (ESTS) and the Japanese Association for Chest Surgery (JACS) via e-mail, providing survey information in both English and Japanese. It consisted of 19 questions addressing the use of HRQoL assessment in clinical practice.RESULTS:In total, we received 234 responses: 84 from ESTS, 128 from JACS and 22 from other societies The present survey showed that 58.5% of surgeons have never collected HRQoL data in their practice. The EORTC-QLQ-LC29 was the most frequently used questionnaire, reported by 24.7% of participants. A total of 137 (59.6%) responses identified HRQoL as the most important PROM. As for timing of data collection, 37.1% responded most important timing of data collection was prior to adjuvant chemotherapy and 24.1% of participants rated HRQoL evaluation six months after surgery.CONCLUSIONS:This study successfully collected responses from thoracic surgeons in both Europe and Japan. Although still underused, these findings highlight that surgeons increasingly recognize the value of PROMs, particularly in the context of multimodal treatment. |
| DOI | 10.1093/ejcts/ezag001 |
| PMID | 41495397 |